SATURDAY, JULY 25, 2026
The Publisher Desk NetworkBreakingSportsEntertainmentLifestyle
Everything Everyone's Talking About
HomeBreakingPoliticsSportsEntertainmentLifestyleTravel
Breaking
•Kids in 'Zombie State' After Eating Spiked Chocolate•Lore accurate "The Odyssey" directed by Elon Musk on Grok ...•The power of film seems to be anything but dead. ...•Big Brother 28: Kamu's Week 3 Nominations Revealed•WSOC Latest Links•Corgi Files for 43 New ETFs - Major Expansion•Kids in 'Zombie State' After Eating Spiked Chocolate•Lore accurate "The Odyssey" directed by Elon Musk on Grok ...•The power of film seems to be anything but dead. ...•Big Brother 28: Kamu's Week 3 Nominations Revealed•WSOC Latest Links•Corgi Files for 43 New ETFs - Major Expansion

Trending stories across breaking news, sports, entertainment and lifestyle. Instant coverage of the stories everyone is talking about.

Sections
  • Breaking
  • Sports
  • Entertainment
  • Lifestyle
Company
  • Join
  • Privacy Policy
  • Contact
Network
  • headlinesplus.com
© 2026 The Publisher Desk. All rights reserved.Headlines Plus — everything everyone's talking about.
Home › Lifestyle

Bryan Johnson Claims He 'Cloned' Himself After Diagnosis

H+Headlines PlusAutoCompiled automatically from 1 source · updated about 2 hours ago
In This StoryAuto-extracted · NER + AI entities
People Mentioned
BJ
Bryan Johnson
Topics
Autoimmune GastritisBiohacking
Read more about this ↗

AI Summary · generated from 1 source

Biohacker Bryan Johnson has made a startling claim after being diagnosed with autoimmune gastritis, saying he has essentially "cloned" himself. Johnson's statement comes as he grapples with the autoimmune condition affecting his digestive system. The entrepreneur, known for his extreme life-extension experiments, suggests he's found a way to preserve or replicate himself amid his health challenges.

Bryan JohnsonAutoimmune GastritisBiohacking

Sources · 0 covering this story

More Across Headlines Plus

Sooners Land Prediction on Elite 2028 Recruit

Korean Sunscreen Ingredient Gets U.S. Approval

Analysts Weigh In on Popular, Nasdaq, Live Oak

Serena Williams on Champions and Comebacks

Discussion